Drugplain

ARISTADA 662 mg/2.4mL

aripiprazole lauroxil · INJECTION, SUSPENSION, EXTENDED RELEASE · Alkermes, Inc.

No Recall History
Plain English

ARISTADA is a injection, suspension, extended release containing aripiprazole lauroxil at 662 mg/2.4mL, taken intramuscular. Manufactured by Alkermes, Inc..

Key Facts

Brand Name
ARISTADA
Generic Name
aripiprazole lauroxil
NDC Code (Product)
65757-402
Manufacturer
Alkermes, Inc.
Strength
662 mg/2.4mL
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Marketing Status
Application #
NDA207533
Marketing Start
10/05/2015

Recall History

No Recall History

Frequently Asked Questions

What is ARISTADA used for?

ARISTADA contains aripiprazole lauroxil. It is a injection, suspension, extended release taken intramuscular. Consult your doctor for specific uses.

Is ARISTADA a controlled substance?

ARISTADA is not classified as a controlled substance by the DEA.

What is the generic name for ARISTADA?

The generic name for ARISTADA is aripiprazole lauroxil. There are 1 other brand versions of aripiprazole lauroxil.

What is the NDC code for ARISTADA 662 mg/2.4mL?

The NDC (National Drug Code) for ARISTADA 662 mg/2.4mL is 65757-402, listed by Alkermes, Inc..

Product NDC

65757-402

Package NDC

65757-402-03

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)